Literature DB >> 9088946

Optimizing collagen antigen unmasking in paraffin-embedded tissues.

K Wakamatsu1, M Ghazizadeh, M Ishizaki, Y Fukuda, N Yamanaka.   

Abstract

In order to optimize collagen antigen unmasking in paraffin-embedded tissue sections, the effects of various fixatives and duration of fixation in relation to enzyme pretreatment and microwave irradiation for collagen antigen unmasking were studied. A streptavidin-biotin-peroxidase complex method was used for the immunolocalization of type III and IV collagen antigens. Fixatives and fixation time had significant adverse effects on the immunoreactivity of the antigens. Enzyme pretreatment was found to be superior to microwave irradiation for collagen antigen unmasking. Fixation with paraformaldehyde required shorter enzyme pretreatment and yielded a more enhanced reaction than treatment with formalin and Bouin's fluid. The optimum conditions for type III and IV collagen unmasking were found to be fixation with 4% paraformaldehyde in 0.01 M phosphate-buffered saline, pH 7.4, for up to 3 weeks followed by enzyme pretreatment with 1 mg ml-1 pepsin in 0.01 N hydrochloric acid, pH 2.0, for 30 min (human tissues) or 60 min (rat tissues) at 37 degrees C. It is concluded that collagen antigen unmasking by enzyme pretreatment in tissue sections fixed for a long period of time can be successful if appropriate enzyme(s) and incubation time(s) are employed with regard to the antigen under study and fixative and fixation time used for tissue preparation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088946     DOI: 10.1023/a:1026468902409

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  3 in total

1.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

2.  Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.

Authors:  Takeshi Arima; Masaaki Uchiyama; Yuichiro Nakano; Shinya Nagasaka; Dedong Kang; Akira Shimizu; Hiroshi Takahashi
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

3.  An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.

Authors:  Masaaki Uchiyama; Akira Shimizu; Yukinari Masuda; Shinya Nagasaka; Yuh Fukuda; Hiroshi Takahashi
Journal:  Mol Vis       Date:  2013-11-01       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.